Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994
- PMID: 23128368
- PMCID: PMC3563287
- DOI: 10.1159/000343885
Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994
Abstract
Background/aims: Nonalcoholic fatty liver disease (NAFLD) has been proposed to contribute to chronic kidney disease (CKD) independently of traditional cardiometabolic risk factors. We hypothesized that NAFLD is associated with CKD and that greater severity of NAFLD is associated with higher odds of CKD.
Methods: A cross-sectional analysis of 11,469 adults who participated in the National Health and Nutrition Examination Survey (NHANES) 1988-1994. NAFLD was defined by ultrasonographic detection of steatosis in the absence of other liver diseases. CKD was defined as an estimated glomerular filtration rate of ≤60 ml/min/1.73 m(2) or the presence of albuminuria in subjects with an estimated glomerular filtration rate of >60 ml/min/1.73 m(2).
Results: 2,891 (25.4%) patients in the cohort had CKD. The prevalence of NAFLD was higher in individuals with CKD compared to those without CKD (42.2 vs. 34.5%, p < 0.0001). NAFLD was associated with CKD in unadjusted logistic regression analysis (OR = 1.47, 95% CI: 1.29-1.67, p < 0.0001). Adjustment for demographics and components of metabolic syndrome attenuated this relationship (OR = 1.04, 95% CI: 0.88-1.23, p = 0.64). Moderate and severe NAFLD on ultrasound were increasingly associated with prevalent CKD in unadjusted analysis, but not after adjustment for metabolic syndrome components.
Conclusion: After adjusting for features of metabolic syndrome, ultrasound-diagnosed NAFLD is not associated with prevalent CKD among US adults. Aggressive public health efforts are needed to prevent and treat metabolic syndrome.
Copyright © 2012 S. Karger AG, Basel.
Conflict of interest statement
Figures
Similar articles
-
MAFLD and risk of CKD.Metabolism. 2021 Feb;115:154433. doi: 10.1016/j.metabol.2020.154433. Epub 2020 Nov 16. Metabolism. 2021. PMID: 33212070
-
Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.Eur J Gastroenterol Hepatol. 2018 Apr;30(4):404-410. doi: 10.1097/MEG.0000000000001045. Eur J Gastroenterol Hepatol. 2018. PMID: 29215435
-
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis.J Cutan Med Surg. 2022 May-Jun;26(3):249-255. doi: 10.1177/12034754211066906. Epub 2021 Dec 12. J Cutan Med Surg. 2022. PMID: 34894782
-
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.PLoS Med. 2014 Jul 22;11(7):e1001680. doi: 10.1371/journal.pmed.1001680. eCollection 2014 Jul. PLoS Med. 2014. PMID: 25050550 Free PMC article. Review.
-
Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis.Metabolism. 2018 Feb;79:64-76. doi: 10.1016/j.metabol.2017.11.003. Epub 2017 Nov 11. Metabolism. 2018. PMID: 29137912 Review.
Cited by
-
Chronic kidney disease and the severity of non-alcoholic fatty liver disease: a systematic review.Rev Assoc Med Bras (1992). 2023 Jul 17;69(7):e20221348. doi: 10.1590/1806-9282.20221348. eCollection 2023. Rev Assoc Med Bras (1992). 2023. PMID: 37466587 Free PMC article. No abstract available.
-
Prevalence of non-alcoholic fatty liver disease in patients with nephrotic syndrome: A population-based study.World J Hepatol. 2023 Feb 27;15(2):265-273. doi: 10.4254/wjh.v15.i2.265. World J Hepatol. 2023. PMID: 36926242 Free PMC article.
-
Association of MAFLD with end-stage kidney disease: a prospective study of 337,783 UK Biobank participants.Hepatol Int. 2023 Jun;17(3):595-605. doi: 10.1007/s12072-023-10486-0. Epub 2023 Feb 21. Hepatol Int. 2023. PMID: 36809487
-
Chronic kidney disease in nonalcoholic fatty liver disease at primary healthcare centers in Korea.PLoS One. 2022 Dec 20;17(12):e0279367. doi: 10.1371/journal.pone.0279367. eCollection 2022. PLoS One. 2022. PMID: 36538567 Free PMC article.
-
Nonalcoholic Fatty Liver Disease before Kidney Transplantation Correlates with New Onset Diabetes and Poor Metabolic Outcomes.Am J Nephrol. 2022;53(8-9):636-645. doi: 10.1159/000526118. Epub 2022 Sep 8. Am J Nephrol. 2022. PMID: 36075195 Free PMC article.
References
-
- Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42(1):44–52. - PubMed
-
- Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, Wasada T. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med. 2005;22(9):1141–1145. - PubMed
-
- Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917–923. - PubMed
-
- Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30(5):1212–1218. - PubMed
-
- Mirbagheri SA, Rashidi A, Abdi S, Saedi D, Abouzari M. Liver: an alarm for the heart? Liver Int. 2007;27(7):891–894. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
